Established in 2005, Vardhman Chemtech Limited (VCL) has grown from a single-reactor plant into one of India’s largest and most integrated manufacturers in the oral and sterile Isoxazoles segment of Penicillin. Today, our portfolio includes industry-leading products such as Cloxacillin Sodium, Dicloxacillin Sodium, Flucloxacillin Sodium, and Oxacillin Sodium.
Key features:
VCL’s products are trusted and exported to over 50 countries worldwide
VCL’s Sterile APIs (injectable) facility in 2010, cemented its position as India’s leading sterile penicillin facility
VCL Highlights
Infrastructure
Capacity of antibiotics:
Isoxazoles: 720 MT p.a.
Cloxa, Flucloxa, Di-cloxa on interchangeable basis
Enzymatic Products: 400 MT p.a.
Amoxy, Ampi on interchangeable basis
Isoxazoles: 720 MT p.a.
Cloxa, Flucloxa, Di-cloxa on interchangeable basis
Enzymatic Products: 400 MT p.a.
Amoxy, Ampi on interchangeable basis
Facilities
Two multi-purpose plants:
Facilities with 60+ reactors, with 3 instrumentation labs and a dedicated sterile unit
Facilities with 60+ reactors, with 3 instrumentation labs and a dedicated sterile unit
Operational Strength
Complete integration:
One of the only two fully integrated Isoxazole manufacturing facilities in the world
One of the only two fully integrated Isoxazole manufacturing facilities in the world
Commitment to Excellence
10+ patents filed:
For process and analytical capabilities
For process and analytical capabilities
Gallery
Vardhman Chemtech Limited (VCL)
Call us for Queries
022-40628300
Pioneering excellence and accessibility in
pharma manufacturing
DPB Group stands as a pillar in the pharmaceutical manufacturing landscape of India, shaping the industry with our innovative practices and consistent quality
